LMW Heparin: New Thromboembolic Applications?
JG Adams
Abstract
JG Adams
Abstract
Previous studies suggest that low-molecular-weight (LMW) heparin is safe and effective for treating proximal deep venous thrombosis. However, these studies largely excluded patients with symptoms of pulmonary embolism (PE) and some patients with a history of venous thromboembolism because they were believed to have more serious thromboembolic disease. Two new studies extend the findings to the full …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Previous studies suggest that low-molecular-weight (LMW) heparin is safe and effective for treating proximal deep venous thrombosis. However, these studies largely excluded patients with symptoms of pulmonary embolism (PE) and some patients with a history of venous thromboembolism because they were believed to have more serious thromboembolic disease. Two new studies extend the findings to the full …
Key concepts: Medicine, Pulmonary embolism, Thromboembolic disease, Heparin, Venous thrombosis, Venous thromboembolism, Thrombosis, Venous thromboembolic disease